Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCNN1A | P37088 | 8/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.63 |
| ▸ | HPGD | P15428 | 6/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.63 |
| ▸ | GLA | P06280 | 5/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.63 |
| ▸ | GAA | P10253 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | PLAU | P00749 | 3/20 | 0.63 |
| ▸ | FTO | Q9C0B1 | 3/20 | 0.63 |
| ▸ | TSHR | P16473 | 3/20 | 0.63 |
| ▸ | BLM | P54132 | 2/20 | 0.63 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.63 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.63 |
| ▸ | HTR1A | P08908 | 1/20 | 0.63 |
| ▸ | MAOA | P21397 | 1/20 | 0.63 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31325583 | 1.00 | SCNN1A (0.63) | SCNN1AALDH1A1HSD17B10KDM4EHPGD | |
| Hydrochloric Acid SCHEMBL11496167 | 0.98 | ALDH1A1 (0.65) | SCNN1AALDH1A1HSD17B10KDM4EHPGD | |
| Acetic Acid SCHEMBL27779574 | 0.92 | SCNN1A (0.56) | SCNN1AALDH1A1HSD17B10KDM4EHPGD | |
| Trifluoroacetic Acid SCHEMBL27779034 | 0.89 | SCNN1A (0.53) | SCNN1AALDH1A1HSD17B10KDM4EHPGD | |
| SCHEMBL14237878 | 0.88 | PLAU (0.50) | SCNN1AALDH1A1HSD17B10KDM4EHPGD | |
| SCHEMBL11778516 | 0.83 | PDPK1 (0.58) | SCNN1AALDH1A1HSD17B10KDM4EHPGD | |
| SCHEMBL23337629 | 0.82 | SCNN1A (0.58) | SCNN1AALDH1A1HSD17B10KDM4EHPGD | |
| SCHEMBL1134621 | 0.82 | SCNN1A (0.58) | SCNN1AALDH1A1HSD17B10KDM4EHPGD | |
| SCHEMBL31647638 | 0.82 | SCNN1A (0.58) | SCNN1AALDH1A1HSD17B10KDM4EHPGD | |
| SCHEMBL25950177 | 0.81 | PLAU (0.44) | SCNN1AALDH1A1HSD17B10KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9587147-B2 | Pressure-sensitive adhesive compositions, polarizers and liquid crystal displays comprising the same | LG CHEM, LTD. (KR) | 2017-03-07 | — | — | US | claimed |
| EP-2230287-B1 | PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS, POLARIZERS AND LIQUID CRYSTAL DISPLAYS COMPRISING THE SAME | LG CHEMICAL LTD (KR) | 2013-06-12 | — | — | EP | claimed |
| CN-101910345-B | Pressure-sensitive adhesive compositions, polarizers and liquid crystal displays comprising the same | LG CHEMICAL LTD | 2013-03-27 | — | — | CN | claimed |
| CN-101687851-B | Organic compounds | NOVARTIS AG | 2013-02-27 | — | — | CN | claimed |
| US-20110200930-A1 | PROCESSES FOR PRODUCING POLYESTER LATEXES VIA SOLVENT-BASED AND SOLVENT-FREE EMULSIFICATION | XEROX CORPORATION (US) | 2011-08-18 | — | — | US | claimed |
| US-20110032455-A1 | PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS, POLARIZERS AND LIQUID CRYSTAL DISPLAYS COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2011-02-10 | — | — | US | claimed |
| EP-2230287-A2 | PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS, POLARIZERS AND LIQUID CRYSTAL DISPLAYS COMPRISING THE SAME | LG Chem, Ltd. (KR) | 2010-09-22 | — | — | EP | claimed |
| CN-101687851-A | organic compounds | NOVARTIS AG | 2010-03-31 | — | — | CN | claimed |
| US-20220249997-A1 | SURFACE MODIFIED FILTER MEDIA | HOLLINGSWORTH & VOSE COMPANY (US) | 2022-08-11 | — | — | US | disclosed |
| US-11292929-B2 | UV curable inkjet inks | AGFA NV (BE) | 2022-04-05 | — | — | US | disclosed |
| US-11266941-B2 | Surface modified filter media | HOLLINGSWORTH & VOSE COMPANY (US) | 2022-03-08 | — | — | US | disclosed |
| US-20220001316-A1 | PRE-COALESCING MULTI-LAYERED FILTER MEDIA | HOLLINGSWORTH & VOSE COMPANY (US) | 2022-01-06 | — | — | US | disclosed |
| CN-108137974-B | UV curable inkjet inks | 爱克发印艺公司 | 2021-09-24 | — | — | CN | disclosed |
| CN-108350295-B | UV curable inkjet inks | 爱克发有限公司 | 2021-08-31 | — | — | CN | disclosed |
| EP-1265866-A2 | ARYL SUBSTITUTED PYRIDINES, PYRIMIDINES, PYRAZINES AND TRIAZINES AND THE USE THEREOF | Euro-Celtique S.A. (LU) | 2002-12-18 | — | — | EP | disclosed |
| US-20020040025-A1 | Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof | PURDUE PHARMA L.P. | 2002-04-04 | — | — | US | disclosed |
| WO-2001068612-A2 | ARYL SUBSTITUTED PYRIDINES, PYRIMIDINES, PYRAZINES AND TRIAZINES AND THE USE THEREOF | EURO-CELTIQUE S.A. (LU) | 2001-09-20 | — | — | WO | disclosed |
| EP-0017153-B1 | NOVEL PYRAZINECARBOXAMIDES, PROCESSES FOR PREPARING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | MERCK & CO. INC. (US) | 1983-01-26 | — | — | EP | disclosed |
| EP-0017153-A1 | Novel pyrazinecarboxamides, processes for preparing and pharmaceutical compositions containing the same | MERCK & CO. INC. (US) | 1980-10-15 | — | — | EP | disclosed |
| US-4224447-A | DIURETICS | MERCK & CO., INC. (US) | 1980-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020040025-A1 | Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof | CACNA1S, KYNU, CACNA1C | SCNN1A 2083/4885ALDH1A1 205/4885HSD17B10 3469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.